Providers and payers are increasing their tech spend

The latest stories trending on MedCity News.

Editor's Pick

Top Story Providers and Payers Are Increasing Their Tech Spend — Where Are They Investing the Most? Three-quarters of U.S. providers and payers say they have increased their IT spending over the past year, according to a new report from Bain & Company and KLAS Research. Both providers and payers are investing in cybersecurity technology, as well as AI tools. Sponsored Connect With Investors & Biopharma Leaders at Biotech Showcase™ 2025 Presented by Biotech Showcase™ & EBD Group Join over 3,200 global biopharma leaders, including 1,200+ investors and 350+ biotech innovators unveiling their latest breakthroughs at Biotech Showcase™, Jan 13–15, 2025. Register now to save $600!

Featured News

Brightside Health Launches Mental Health Services for Teens Brightside Health is expanding to serve teens ages 13 to 17. These teens can receive therapy and psychiatry services and will eventually have access to the company's Crisis Care support. From Silos to Synergy: Integrating Clinical Teams into Agile Product Workflows Whether creating a health application or platform-based solutions, the effectiveness of innovation in healthtech relies not only on scientifically backed up technology, but more on consumer-driven design, highlighting the need for precision and efficiency. Doubling Down on Falls: How Technology is Redefining Fall Prevention Integrating comprehensive risk assessment tools that identify fall risks early can enable healthcare providers to implement personalized preventive measures, such as tailored exercise and physical therapy programs that strengthen mobility and balance among at-risk individuals.

Resources

Debunked | No-Fluff Healthcare News Show | Presented by MedCity News | Episode 8 In this episode, we address a judge's ruling against FTC's ban on non-compete clauses in employment contracts and its implications for healthcare workers. Also, Pfizer's launch of a digital platform providing easy access to providers and medications for migraine patients and vaccine seekers. Finally, Johnson & Johnson's attempt to modify its 340B drug discount program, which offers reduced prices on outpatient medications to hospitals serving uninsured patients. Watch Now

MedCity News • PO Box 901 • New York, NY unsubscribe